Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Nektar Therapeutics
About NKTR
Nektar Therapeutics is a clinical-stage biotechnology company. It is focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body’s immune response to fight cancer. Its lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel regulatory T cell stimulator being evaluated in two Phase IIb clinical trials, one in atopic dermatitis and one in alopecia areata. Its pipeline also includes a preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422. It is also evaluating NKTR-255, an investigational IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer, in several ongoing clinical trials.
Find out what a historical investment in Nektar Therapeutics would be worth today using our NKTR stock calculator.
Market Capitalisation
$2.39B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.27M
High today
$73.81
Low today
$69.38
Open price
$73.51
52-week high
$109.00
52-week low
$7.99
Ready to start your investing journey with Stake?
Open an accountHow do I buy NKTR shares in Australia?
Buying NKTR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Nektar Therapeutics in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NKTR
What is the ticker symbol of Nektar Therapeutics?
The ticker symbol for Nektar Therapeutics is NKTR.
How much is one share of NKTR?
One share of NKTR is valued at $70.26 as of 16 May 2026.
What is the market capitalisation of Nektar Therapeutics NKTR?
As of 16 May 2026 Nektar Therapeutics has a market cap of $2.39B.
What is the 52-week high for Nektar Therapeutics stock?
The Nektar Therapeutics 52-week high stock price is $109.00.
What is the 52-week low for Nektar Therapeutics stock?
The Nektar Therapeutics 52-week low stock price is $7.99.
Can I buy NKTR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NKTR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NKTR on Stake
- Buy NKTR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NKTR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NKTR related stocks